Search results for "Atrial fibrillation"
MKSAP quiz on atrial fibrillation
Cases involving various afib-related diagnoses are presented.
https://acphospitalist.acponline.org/archives/2015/06/MKSAP-afib.htm
15 Jun 2015
New COVID-19 boosters, biosimilar for MS OK’ed
The FDA approved updated COVID-19 vaccines and the first-ever biosimilar for multiple sclerosis (MS), among other recent actions.
https://acphospitalist.acponline.org/archives/2023/10/04/new-covid-19-boosters-biosimilar-for-ms-oked.htm
4 Oct 2023
Troponin level may help predict mortality in patients admitted with afib
Troponin levels were associated with risk for death, and coronary angiography was associated with both higher troponin levels and lower mortality.
https://acphospitalist.acponline.org/weekly/archives/2020/04/01/6.htm
1 Apr 2020
Early anticoagulation appears safe after acute ischemic stroke in patients with afib
The AREST trial, which ended early due to changes in national guidelines, found statistically similar but numerically lower rates of the primary study outcome (fatal stroke, recurrent ischemic stroke, or transient ischemic attack) in those who received anticoagulation early with apixaban versus later with warfarin.
https://acphospitalist.acponline.org/weekly/archives/2021/03/03/5.htm
3 Mar 2021
Test Yourself: MKSAP quiz on atrial fibrillation
These cases and commentary, which address atrial fibrillation, are excerpted from ACP's Medical Knowledge Self-Assessment Program (MKSAP15).
https://acphospitalist.acponline.org/archives/2012/08/ty.htm
15 Aug 2012
Update released on using dabigatran to manage atrial fibrillation
Several cardiology specialty societies have released a focused update on managing patients with atrial fibrillation to include the option of using dabigatran, the first new oral anticoagulant available for clinical use in more than 50 years.
https://acphospitalist.acponline.org/weekly/archives/2011/03/02/1.htm
2 Mar 2011
Review finds 18% mortality in severe DOAC-related bleeding treated with reversal agent
A systematic review looked at 60 studies that evaluated four-factor prothrombin complex concentrates, idarucizumab, or andexanet for the treatment of severe or uncontrolled bleeding in patients on a direct oral anticoagulant (DOAC).
https://acphospitalist.acponline.org/weekly/archives/2021/06/16/4.htm
16 Jun 2021
Decision pathway addresses bleeding in patients on oral anticoagulants
The guidance from the American College of Cardiology covers management of major and minor bleeding in patients treated with direct-acting oral anticoagulants or vitamin K antagonists for any indication.
https://acphospitalist.acponline.org/weekly/archives/2020/07/22/4.htm
22 Jul 2020
Duty hours, infective endocarditis
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2019/08/recent-research.htm
15 Aug 2019
1 in 3 adults with new-onset a fib during hospitalization have recurrence within a year
The findings suggest that patients who experience a transient episode of atrial fibrillation during hospitalization need risk stratification and follow-up, according to the authors of the matched cohort study.
https://acphospitalist.acponline.org/archives/2023/10/04/1-in-3-adults-with-new-onset-a-fib-during-hospitalization-have-recurrence-within-a-year.htm
4 Oct 2023